125 related articles for article (PubMed ID: 38159994)
1. Sex-specific Real-World 5-year Overall Survival Rates for (Radio)chemotherapy, Targeted Therapy, and Combinations in Patients With Head and Neck Cancer.
Baudrexl J; Pietzka S; Scheurer M; Schramm A; Wilde F; Sakkas A; Derka S; Ebeling M
Anticancer Res; 2024 Jan; 44(1):267-286. PubMed ID: 38159994
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Five-year Overall Survival Rates Among 18,331 Head and Neck Cancer Patients Exposed to Different Targeted Therapies Through Real-world Data in a Case-controlled Study.
Baudrexl J; Sakkas A; Pietzka S; Derka S; Vairaktari G; Scheurer M; Schramm A; Wilde F; Ebeling M
Anticancer Res; 2024 Mar; 44(3):1247-1270. PubMed ID: 38423635
[TBL] [Abstract][Full Text] [Related]
3. Survival predictors and outcomes of patients with recurrent and/or metastatic head and neck cancer treated with chemotherapy plus cetuximab as first-line therapy: A real-world retrospective study.
Pontes F; Garcia AR; Domingues I; João Sousa M; Felix R; Amorim C; Salgueiro F; Mariano M; Teixeira M
Cancer Treat Res Commun; 2021; 27():100375. PubMed ID: 33882378
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic decision making in stages III and IV head and neck squamous cell carcinoma.
Gleich LL; Collins CM; Gartside PS; Gluckman JL; Barrett WL; Wilson KM; Biddinger PW; Redmond KP
Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):26-35. PubMed ID: 12525191
[TBL] [Abstract][Full Text] [Related]
5. Survival impact of induction chemotherapy in advanced head and neck cancer: A National Cancer Database analysis.
Stokes WA; Amini A; Jones BL; McDermott JD; Raben D; Ghosh D; Goddard JA; Bowles DW; Karam SD
Head Neck; 2017 Jun; 39(6):1113-1121. PubMed ID: 28301079
[TBL] [Abstract][Full Text] [Related]
6. Nutritional factors as predictors of response to radio-chemotherapy and survival in unresectable squamous head and neck carcinoma.
Salas S; Deville JL; Giorgi R; Pignon T; Bagarry D; Barrau K; Zanaret M; Giovanni A; Bourgeois A; Favre R; Duffaud F
Radiother Oncol; 2008 May; 87(2):195-200. PubMed ID: 18342966
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy for primary cancer can reduce the risk of head and neck second primary malignancy: a propensity-matched analysis.
Xiong L; Yu H; Wei W; Wang C; Li B; Liu H; Cheng A; Li D; Han Z; Feng Z
Clin Oral Investig; 2023 Feb; 27(2):571-580. PubMed ID: 36239788
[TBL] [Abstract][Full Text] [Related]
9. Elderly patients with squamous cell carcinoma of the head and neck and the benefit of multimodality therapy.
Moye VA; Chandramouleeswaran S; Zhao N; Muss HB; Weissler MC; Hayes DN; Zevallos JP
Oncologist; 2015 Feb; 20(2):159-65. PubMed ID: 25582139
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumors.
Schäfer U; Micke O; Müller SB; Schüller P; Willich N
Strahlenther Onkol; 2003 Aug; 179(8):527-34. PubMed ID: 14509951
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of hemoglobin concentrations in patients with advanced head and neck cancer treated with combined radio-chemotherapy and surgery.
Wagner W; Hermann R; Hartlapp J; Esser E; Christoph B; Müller MK; Krech R; Koch O
Strahlenther Onkol; 2000 Feb; 176(2):73-80. PubMed ID: 10697654
[TBL] [Abstract][Full Text] [Related]
12. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
13. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
14. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.
Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J
J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405
[TBL] [Abstract][Full Text] [Related]
15. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
[TBL] [Abstract][Full Text] [Related]
17. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
[TBL] [Abstract][Full Text] [Related]
18. Outcomes Among Patients With Mucosal Head and Neck Squamous Cell Carcinoma Treated With Checkpoint Inhibitors.
Hobday SB; Brody RM; Kriegsman B; Basu D; Newman J; Cohen RB; Lukens JN; Singh A; D'Avella CA; Sun L
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):918-926. PubMed ID: 35980666
[TBL] [Abstract][Full Text] [Related]
19. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.
Murphy JD; La TH; Chu K; Quon A; Fischbein NJ; Maxim PG; Graves EE; Loo BW; Le QT
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):514-21. PubMed ID: 20646870
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid Carcinoma in the Head and Neck: A Population-Based Analysis of Outcome and Survival.
Ding L; Bi ZF; Yuan H; Zhao XH; Guan XD; Yao HR; Liu YM
Laryngoscope; 2021 Feb; 131(2):E489-E499. PubMed ID: 33135805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
